The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications DM Lambert, CJ Fowler Journal of medicinal chemistry 48 (16), 5059-5087, 2005 | 460 | 2005 |
The effect of age on the activity and molecular properties of human brain monoamine oxidase CJ Fowler, Å Wiberg, L Oreland, J Marcusson, B Winblad Journal of neural transmission 49, 1-20, 1980 | 431 | 1980 |
The palmitoylethanolamide family: a new class of anti-inflammatory agents? DM Lambert, S Vandevoorde, KO Jonsson, CJ Fowler Current medicinal chemistry 9 (6), 663-674, 2002 | 362 | 2002 |
The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 310 | 2017 |
Monoamine oxidase A and B: a useful concept? CJ Fowler, BA Callingham, TJ Mantle, KF Tipton Biochemical Pharmacology, 1978 | 294 | 1978 |
The deamination of dopamine by human brain monoamine oxidase: specificity for the two enzyme forms in seven brain regions AM O'Carroll, CJ Fowler, JP Phillips, I Tobbia, KF Tipton Naunyn-Schmiedeberg's archives of pharmacology 322, 198-202, 1983 | 287 | 1983 |
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain P Anand, G Whiteside, CJ Fowler, AG Hohmann Brain research reviews 60 (1), 255-266, 2009 | 258 | 2009 |
The concise guide to PHARMACOLOGY 2015/16: Overview SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ... British journal of pharmacology 172 (24), 5729-5743, 2015 | 243 | 2015 |
Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors SOP Jacobsson, T Wallin, CJ Fowler Journal of Pharmacology and Experimental Therapeutics 299 (3), 951-959, 2001 | 223 | 2001 |
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide KO Jonsson, S Vandevoorde, DM Lambert, G Tiger, CJ Fowler British journal of pharmacology 133 (8), 1263-1275, 2001 | 209 | 2001 |
Selective inhibitors of monoamine oxidase A and B: biochemical, pharmacological, and clinical properties CJ Fowler, SB Ross Medicinal research reviews 4 (3), 323-358, 1984 | 194 | 1984 |
Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement … S Holt, F Comelli, B Costa, CJ Fowler British journal of pharmacology 146 (3), 467-476, 2005 | 189 | 2005 |
Transport of endocannabinoids across the plasma membrane and within the cell CJ Fowler The FEBS journal 280 (9), 1895-1904, 2013 | 184 | 2013 |
Platelet monoamine oxidase activity in sensation seekers CJ Fowler, L von Knorring, L Oreland Psychiatry Research 3 (3), 273-279, 1980 | 181 | 1980 |
Human platelet monoamine oxidase—A useful enzyme in the study of psychiatric disorders? CJ Fowler, KF Tipton, AVP Mackay Neuroscience 7 (7), 1577-1594, 1982 | 172 | 1982 |
Low platelet monoamine oxidase activity in cigarette smokers L Oreland, CJ Fowler, D Schalling Life Sciences 29 (24), 2511-2518, 1981 | 172 | 1981 |
Deamination of 5‐hydroxytryptamine by both forms of monoamine oxidase in the rat brain CJ Fowler, KF Tipton Journal of neurochemistry 38 (3), 733-736, 1982 | 163 | 1982 |
‘Entourage’ effects of N‐acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide‐induced vanilloid receptor activation and upon … D Smart, KO Jonsson, S Vandevoorde, DM Lambert, CJ Fowler British journal of pharmacology 136 (3), 452-458, 2002 | 162 | 2002 |
Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase CJ Fowler Biochemical pharmacology 30 (24), 3329-3332, 1981 | 159 | 1981 |
The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline CJ Fowler, TJ Mantle, KF Tipton Biochemical pharmacology 31 (22), 3555-3561, 1982 | 153 | 1982 |